ACM Global Central Lab Launches Workshop Series to Share Expert Insights on Navigating Global Clinical Trials with a Central Lab

irst Event to Feature Expert Panel Offering Scientific, Financial and Logistical Considerations for Ensuring Patient Safety

Rochester, NY, Feb. 28, 2012 - ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, today announced the launch of its complimentary workshop series, “Navigating Global Clinical Trials with Your Central Lab,” designed for global pharmaceutical and biotechnology companies and contract research organizations (CROs) interested in managing global clinical trials testing. The first workshop, “Ensuring Patient Safety through Efficient Specimen Lifecycle Management,” will take place Thursday, March 15, 2012, from 2:00 – 5:00 p.m. PST at Hotel Vitale in San Francisco.

In many clinical trial scenarios, there may only be one chance to collect, ship, test and analyze a patient’s specimen. These often time-sensitive snapshots into a patient’s progression in a study are critical not only to the overall study results, but ultimately the safety of patients undergoing treatment. The lifecycle of a specimen, which starts at collection and ends at database lock, can be prone to human error along each step of the testing process, particularly when conducting global clinical trials in more remote ends of the world. Sponsors need to ensure the integrity of the specimen throughout this process, while balancing the relative cost of logistics.

“There are many considerations when it comes to conducting global studies,” said Tracy Hendershott, vice president of clinical trials at ACM Global Central Lab. “As a central lab devoted to clinical trials testing, we wanted to develop a workshop series to support the clinical trials community by helping them navigate the many hurdles and offer some new approaches that can improve efficiencies along the way.”

Executives from ACM Global Central Lab, Cryoport and Dorevitch Pathology will be discussing the scientific, financial and logistical factors that should be considered to ensure patient safety and will offer innovative, yet cost-effective methodologies and solutions for maintaining specimen integrity. During interactive presentations and a networking reception, attendees will have the opportunity to hear from ACM Global Lab and its partners on their insights on monitoring and oversight on patient safety, safeguarding sample integrity, and good business sense, based on lessons learned from managing global clinical trials testing.

To register for ACM Global Central Lab’s complimentary workshop, please click here. Registrants will automatically qualify to be entered into a drawing for a “Sunset Sailing Experience for Two” around the San Francisco Bay.

About ACM Global Central Laboratory
ACM Global Central Lab offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM’s services extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting.

For more information, visit www.acmgloballab.com and our Central Labs in Focus blog at www.acmgloballab.com/blog

email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement